These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Inhibition of cell-surface neutral protease of Ehrlich ascites tumor cells by potassium p-(3,3-dimethyl-1-triazeno) benzoate. Steven FS; Brown BS; Hulley TP; Itzhaki S; Giraldi T; Lassiani L Biochem Int; 1985 Aug; 11(2):153-60. PubMed ID: 3902023 [TBL] [Abstract][Full Text] [Related]
44. Treatment of metastases of solid mouse tumours by NAMI-A: comparison with cisplatin, cyclophosphamide and dacarbazine. Sava G; Gagliardi R; Bergamo A; Alessio E; Mestroni G Anticancer Res; 1999; 19(2A):969-72. PubMed ID: 10368640 [TBL] [Abstract][Full Text] [Related]
45. Enhanced metastatic potential of cloned low-metastatic Lewis lung carcinoma cells treated in vitro with dimethyl sulfoxide. Takenaga K Cancer Res; 1984 Mar; 44(3):1122-7. PubMed ID: 6692398 [TBL] [Abstract][Full Text] [Related]
46. Antimetastatic effect of a lipophilic ascorbic acid derivative with antioxidation through inhibition of tumor invasion. Liu J; Zhang X; Yang F; Li T; Wei D; Ren Y Cancer Chemother Pharmacol; 2006 May; 57(5):584-90. PubMed ID: 16075276 [TBL] [Abstract][Full Text] [Related]
47. The effect of functional groups on reduction and activation of quinone bioreductive agents by DT-diaphorase. Fourie J; Oleschuk CJ; Guziec F; Guziec L; Fiterman DJ; Monterrosa C; Begleiter A Cancer Chemother Pharmacol; 2002 Feb; 49(2):101-10. PubMed ID: 11862423 [TBL] [Abstract][Full Text] [Related]
48. Experimental studies at Southern Research Institute with DTIC (NSC-45388). Montgomery JA Cancer Treat Rep; 1976 Feb; 60(2):125-34. PubMed ID: 1260770 [TBL] [Abstract][Full Text] [Related]
49. Potential of the aminosterol, squalamine in combination therapy in the rat 13,762 mammary carcinoma and the murine Lewis lung carcinoma. Teicher BA; Williams JI; Takeuchi H; Ara G; Herbst RS; Buxton D Anticancer Res; 1998; 18(4A):2567-73. PubMed ID: 9703911 [TBL] [Abstract][Full Text] [Related]
50. [Anti-metastatic effect of vascular endothelial growth factor receptor 2 extracellular domain gene-modified dendritic cell vaccination in murine model with experimental pulmonary metastasis]. Pan JP; Weng YS; Wu QQ Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):646-9. PubMed ID: 17274366 [TBL] [Abstract][Full Text] [Related]
51. GLB prevents tumor metastasis of Lewis lung carcinoma by inhibiting tumor adhesion actions. Pan Y; Song QL; Lin YH; Lu N; Yu HM; Li XJ Acta Pharmacol Sin; 2005 Jul; 26(7):881-6. PubMed ID: 15960897 [TBL] [Abstract][Full Text] [Related]
52. UFT inhibits lung metastases in spontaneous metastasis model of lung cancer. Miyahara R; Nakagawa T; Ishikawa S; Fukushima M; Wada H; Tanaka F Thorac Cardiovasc Surg; 2005 Apr; 53(2):118-21. PubMed ID: 15786012 [TBL] [Abstract][Full Text] [Related]
53. Comparison of the metastatic properties of B16 melanoma clones isolated from cultured cell lines, subcutaneous tumors, and individual lung metastases. Poste G; Doll J; Brown AE; Tzeng J; Zeidman I Cancer Res; 1982 Jul; 42(7):2770-8. PubMed ID: 7083167 [TBL] [Abstract][Full Text] [Related]
54. Inhibition of experimental lung metastases of Lewis lung carcinoma cells by chemically modified heparin with reduced anticoagulant activity. Yoshitomi Y; Nakanishi H; Kusano Y; Munesue S; Oguri K; Tatematsu M; Yamashina I; Okayama M Cancer Lett; 2004 Apr; 207(2):165-74. PubMed ID: 15072825 [TBL] [Abstract][Full Text] [Related]
55. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653 [TBL] [Abstract][Full Text] [Related]
56. Anticancer effect of 4-[3,5-bis(trimethylsilyl)benzamido] benzoic acid (TAC-101) against A549 non-small cell lung cancer cell line is related to its anti-invasive activity. Shibata J; Murakami K; Wierzba K; Aoyagi Y; Hashimoto A; Sano M; Toko T; Yamada Y Anticancer Res; 2000; 20(5A):3169-76. PubMed ID: 11062739 [TBL] [Abstract][Full Text] [Related]
57. Tumor cell metastasis and surface neutral proteinase: effects of antimetastatic and antitumor drugs. Giraldi T; Sava G; Perissin L; Zorzet S; Decorti G; Steven FS Invasion Metastasis; 1985; 5(6):336-43. PubMed ID: 3905687 [TBL] [Abstract][Full Text] [Related]
58. In vitro activation of dacarbazine (DTIC) for a human tumor cloning system. Metelmann HR; Von Hoff DD Int J Cell Cloning; 1983 Apr; 1(1):24-32. PubMed ID: 6674387 [TBL] [Abstract][Full Text] [Related]
59. Differences in drug sensitivity among tumor cells from parental tumors, selected variants, and spontaneous metastases. Tsuruo T; Fidler IJ Cancer Res; 1981 Aug; 41(8):3058-64. PubMed ID: 7248962 [TBL] [Abstract][Full Text] [Related]
60. Administration of recombinant interleukin 12 prevents outgrowth of tumor cells metastasizing spontaneously to lung and lymph nodes. Mu J; Zou JP; Yamamoto N; Tsutsui T; Tai XG; Kobayashi M; Herrmann S; Fujiwara H; Hamaoka T Cancer Res; 1995 Oct; 55(19):4404-8. PubMed ID: 7671253 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]